Neoasia

What Neoasia does

Neoasia is a Singapore-headquartered medical aesthetic distribution company founded in 1995, serving clinics, dermatologists, plastic surgeons, and aesthetic medicine practitioners across Southeast Asia. The company does not develop products itself; instead, it acts as the regional distribution partner for a portfolio of roughly 30 international brands, organized into three categories: Skincare & Oral Supplements (e.g., Neoretin, NeoStrata, Mesoestetic, Heliocare, Endocare, AnteAGE), Medical Devices (e.g., TSK needles, Tropocells PRP, Profhilo, Aliaxin, iGrow), and Medical Aesthetic Equipment (e.g., Hydrafacial, DEKA SmartXide and MonaLisa Touch, Quanta System Discovery PICO, Syneron Candela Vbeam, Cooltech Define). Several of these brands carry proprietary technologies licensed into Neoasia's distribution, such as Cantabria Labs' RetinSphere and Whitening Booster System, NeoStrata's AHA/Glycolic Acid platform, and RevitaLash's BioPeptin Complex.

Neoasia operates regional offices in Singapore (headquarters), Vietnam (Ho Chi Minh City and Hanoi), Hong Kong, and Indonesia, and distributes products directly to clinics and hospitals through this B2B channel. The revenue model is product distribution, with the mix spanning consumable skincare, recurring injectable and PRP consumables, and one-time capital equipment sales. Pricing is quote-based and not publicly disclosed. The company supports its brands through regional scientific symposiums, clinical forums, and award ceremonies that drive clinical adoption among aesthetic professionals.

The firm is privately held, employs 51-100 people, and is led by Chief Executive Officer Heng Hui Chen with founder Jimmy Ang. The company's competitive position rests on 30 years of regional relationships, exclusive or authorized distribution mandates for premium international brands, and a multi-market Southeast Asian footprint that is time-consuming for competitors to replicate.

Name

Neoasia

Legal name

Neoasia

Website

https://neoasia.com.sg

Company type

Private

Founded year

1995

Operating status

Operating

Headcount range

51–100 employees

Ownership category

akta.pro rank

Product category

Medical Aesthetic Distribution

NAICS

Drugs and Druggists' Sundries Merchant Wholesalers (42421), Cosmetics, Beauty Supplies, and Perfume Retailers (456120)

SIC

Perfumes, Cosmetics & Other Toilet Preparations (2844), Surgical & Medical Instruments & Apparatus (3841)

akta.pro primary industry

Dermocosmetics & Medical-Grade Skincare (CRABAAAF)

akta.pro secondary industries

Professional Skincare & Facial Treatments (CRABALAF), Dermatology & Topical Skin Treatments (HLAIADAE), Dermatology Specialty Pharmaceuticals (HLAIACAL), Sun Protection for Sensitive/Medical Needs (Reef-Safe, Hypoallergenic, Post-Procedure) (CRABAHAN)

Keywords

• Medical aesthetic distribution
• Skincare distribution
• Medical device distribution
• Aesthetic laser equipment
• Dermatology products

Headquarters

HQ city

Midview City

HQ country

Singapore

HQ region

Asia

Offices5 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Operations, Supply Chain, Personnel, Marketing or Sales, Infrastructure

Revenue model

1. Product Distribution: Neoasia generates revenue through distributing medical aesthetic technologies and skincare products to clinics, hospitals, and medical professionals across Asia. The company acts as the exclusive or authorized regional distributor for multiple international brands including Neoretin, NeoStrata, Mesoestetic, Heliocare, Endocare, Profhilo, Hydrafacial, and various laser and device manufacturers.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels3 records

Core offering

Neoasia is a regional distribution partner for medical aesthetic technologies in Asia, distributing third-party skincare products, oral supplements, medical devices (including hyaluronic acid injectables and PRP systems), and medical aesthetic equipment (such as lasers, IPL platforms, and body contouring devices) to clinics, hospitals, and medical professionals across Singapore, Vietnam, Hong Kong, and Indonesia. The company holds exclusive or authorized distribution rights for premium international brands including Cantabria Labs' portfolio (Neoretin, Heliocare, Endocare), NeoStrata, Mesoestetic, IBSA's Profhilo and Aliaxin, DEKA Laser, Quanta System, Syneron Candela, Hydrafacial, and TSK, providing product availability alongside clinical education, training, and professional support to the aesthetic medicine channel.

Product overview

Neoasia is a distribution company for medical aesthetic technologies in Asia since 1995. The product portfolio spans three categories: (1) Skincare & Oral Supplements including 13 brands (Neoretin, NeoStrata, Mesoestetic, Heliocare, Endocare, ACM Laboratoire, Aknicare, AnteAge, Enerpeel, Exuviance, Revitalash, Rosacure, Vivier) covering anti-aging, lightening, photoprotection, acne, and regenerative skincare; (2) Medical Devices including 6 brands (TSK, Tropocells, Profhilo, Magic Needles, iGrow, Aliaxin) covering PRP systems, hyaluronic acid injectables, hair rejuvenation, and dermal fillers; and (3) Medical Aesthetic Equipment including 15 brands (Hydrafacial, Discovery PICO, Cooltech Define, 585, BiAxis QS, Iskra Medical, Liftera, Monalisa Touch, Motus AX, NeoGen, Nordlys, Onda, Primelase Excellence, SmartXide, Vbeam) covering lasers, IPL systems, plasma technology, and body contouring devices.

Differentiator

Problem solved

Functional benefit

Brands

• Neoasia Group: Parent corporate brand for Neoasia's medical aesthetic distribution operations

Products and services

• Neoretin Distributed anti-aging and skin-lightening skincare line by Cantabria Labs that uses RetinSphere Technology and Whitening Booster System to comprehensively renew the epidermis, improve skin texture, reduce wrinkles, and unify skin tone; sold to medical aesthetic professionals for patient treatments.
• NeoStrata Distributed skincare brand founded on Alpha Hydroxy Acid (AHA) research with over 40 years of topical skincare ingredient development, including patented Glycolic Acid formulations licensed worldwide; supplied to medical aesthetic clinics and professionals across Asia.
• Mesoestetic Distributed professional treatment products with scientifically proven results, customized to individual patient needs to optimize outcomes; intended for medical aesthetic clinics delivering a range of skin treatments.
• Heliocare Distributed photoprotection brand researched and developed by Cantabria Labs since 2001, manufacturing superior pharmaceuticals, dermatologicals, and cosmetic products with research-backed formulations for safe and effective dermatological use.
• Endocare Distributed dermatological brand developed by Cantabria Labs since 1997, manufacturing superior pharmaceuticals and cosmetic products with heavy R&D investment to ensure products are safe and effective for professional skin treatments.
• ACM Laboratoire Distributed French brand founded in 2001 that develops and markets medicines, cosmetic products, and food supplements offering innovative solutions for hyperpigmentation, acne, rosacea, and hair loss; intended for dermatology and aesthetic practitioners.
• Aknicare Distributed topical acne treatment clinically proven to work on hyperseborrhea by targeting all four acne pathogenesis factors without the use of antibiotics, retinoids, or steroids; intended for dermatology practices.
• AnteAGE Distributed regenerative anti-aging products using pioneering human bone marrow stem cell technology in aesthetics and dermatology, providing evidence-based regenerative treatments to medical professionals.
• Enerpeel Distributed chemical exfoliation product line by Tebitech developed for treatment of specific skin problems at various skin depths, designed to exfoliate and stimulate skin rejuvenation in professional settings.
• Exuviance Distributed clinically proven skincare products that correct uneven skin tone and lighten pigmentations, developed to be safe and effective in correcting and preventing signs of aging for all skin types.
• RevitaLash Distributed eyelash and eyebrow enhancement products utilizing proprietary BioPeptin Complex technology with powerful peptides and age-defying antioxidants for natural lash and brow enhancement.
• Rosacure Distributed skincare range specially designed to ease symptoms and enhance rosacea treatment using Polyglutamic Acid, Butyl Cyclohexanol, and MSM to target receptors and chemical mediators triggering rosacea.
• Vivier Distributed Canadian medical-grade skincare brand established in 2000, providing pharmaceutical-grade skincare solutions for the treatment, maintenance, and protection of the skin for medical professionals.
• TSK Distributed medical device brand founded in 1948 by Yonesaburou Kawashima, offering medical needles including injection and surgical needles with innovations throughout the 1980s-1990s for use in aesthetic medicine.
• Tropocells Distributed advanced Platelet Rich Plasma (PRP) preparation system designed for easy extraction of pure, significant, and highly effective PRP for aesthetic medicine applications.
• Profhilo Distributed BDDE-free stabilised injectable hyaluronic acid (HA) product by IBSA that bio-stimulates four types of collagen, elastin, and proliferates adipocyte stem cells to address skin laxity and signs of skin aging.
• Magic Needles Distributed precision medical needles developed by Needle Concept in France for aesthetic medicine applications, with rigorous testing for global market launch.
• iGrow Distributed hair rejuvenation device leveraging a patent-pending combination of built-in laser and LED light devices with over 50 light sources to provide complete scalp coverage for hair restoration treatments.
• Aliaxin Distributed IBSA intracutaneous dermal filler range containing ultrapure Hyaluronic Acid with six different formulations targeting 12 facial areas for aesthetic medicine practitioners.
• Hydrafacial Distributed celebrity facial treatment device performed every 15 seconds worldwide, used by clinics for non-invasive skin rejuvenation and hydration treatments.
• Discovery PICO Distributed medical laser by Quanta System addressing melasma, sun spots, age spots, freckles, birthmarks, and tattoo removal for aesthetic clinics.
• Cooltech Define Distributed cryoadipolysis device for fat reduction featuring four simultaneous handpieces that reduce treatment time and improve patient comfort.
• 585 Laser Distributed Quanta System laser using D-wmops technology, the first to emit Dye laser wavelengths in continuous or pulsed modes for medical aesthetic applications.
• BiAxis QS Distributed Q-switched Nd:YAG laser for treating pigmented lesions, tattoos, collagen remodeling, and excessive hair removal at 1064nm and 532nm wavelengths.
• Iskra Medical Distributed medical device manufacturer portfolio for physiotherapy, rehabilitation, and aesthetic medicine, supplied to clinics across Neoasia's Asian markets.
• Liftera Distributed non-invasive lifting and contouring treatment using Thermal Diffusion Treatment (TDT) technology for face, neck, and body aesthetic procedures.
• MonaLisa Touch Distributed fractional CO2 laser by DEKA Laser for functional vaginal rejuvenation treatment of vaginal mucosa in aesthetic gynecology procedures.
• Motus AX Distributed compact Alexandrite 755nm laser system combining high capability with safety and comfort for hair removal treatments in aesthetic clinics.
• NeoGen Distributed nitrogen plasma system by Energist delivering ablative-like skin rejuvenation results with the safety and healing profile of a non-ablative device.
• Nordlys Distributed IPL system with narrowband technology and patented dual filters used for photorejuvenation, vascular treatments, and hair removal by aesthetic medicine practitioners.
• Onda Distributed microwave system by DEKA Laser that targets subcutaneous fat safely with integrated cooling for patient comfort in body contouring treatments.
• Primelase Excellence Distributed US FDA-cleared multi-treatment diode laser platform with 4,800W peak power for high-performance hair removal and aesthetic treatments.
• SmartXide Distributed CO2 laser combined with radiofrequency by DEKA Laser for skin imperfection correction and anti-aging stimulation of neocollagenesis in aesthetic clinics.
• Vbeam Distributed pulsed dye laser series by Syneron Candela used by clinicians for vascular and pigmented skin lesion treatments.

Segments1 record

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Partnerships

Nine partnerships are on record, tiered core.

• Cantabria LabscoreTechnology or IntegrationCantabria Labs is the manufacturer behind Neoretin, Heliocare, and Endocare brands. The company focuses on manufacturing superior pharmaceuticals, dermatologicals, and cosmetic products with heavy investment in R&D. Neoasia distributes their complete skincare portfolio across Asian markets.
• NeoStratacoreTechnology or IntegrationNeoStrata, the founder of Alpha Hydroxy Acid (AHA), has been researching topical skincare ingredients for over 40 years, discovering and patenting technologies like Glycolic Acid licensed worldwide. Neoasia distributes their complete skincare range.
• MesoesteticcoreTechnology or IntegrationMesoestetic is committed to the development and marketing of top-quality products with scientifically proven results. The brand customizes professional treatments to each patient's needs. Neoasia distributes their professional treatment products.
• IBSA (Profhilo, Aliaxin)coreTechnology or IntegrationIBSA created Profhilo (BDDE-free stabilised injectable hyaluronic acid for skin laxity) and Aliaxin (complete intradermal dermal filler range). Neoasia distributes these injectable aesthetic products in Asia.
• DEKA Laser (SmartXide, MonaLisa Touch, Onda)coreTechnology or IntegrationDEKA Laser manufactures CO2 lasers, vaginal rejuvenation systems (MonaLisa Touch), and microwave systems (Onda) for body contouring. Neoasia distributes their medical aesthetic equipment portfolio.
• Quanta System (Discovery PICO, 585)coreTechnology or IntegrationQuanta System manufactures innovative medical lasers including Discovery PICO (pico-second laser for pigmentation and tattoos) and the 585 laser with D-wmops technology. Neoasia distributes these laser devices.
• Syneron Candela (Vbeam)coreTechnology or IntegrationSyneron Candela manufactures the Vbeam Series pulsed dye lasers for vascular and pigmented skin lesion treatments. Neoasia distributes their laser technology in Asian markets.
• TSK GroupcoreTechnology or IntegrationTSK Group, founded in 1948, manufactures medical needles including injection and surgical needles. The founder received the 'Order of the Rising Sun' from Emperor Akihito in 2011. Neoasia distributes their medical device products.
• HydrafacialcoreTechnology or IntegrationHydrafacial is known as the 'celebrity facial' treatment performed every 15 seconds worldwide. Neoasia distributes Hydrafacial devices and products in their regional markets.

Scale indicators2 records

Recent moves1 record

Expansion highlights5 records

Direct peers

• DKSH Holding: Swiss-listed market expansion services group with a sizable healthcare and consumer goods distribution business across Asia. Comparable to Neoasia as a B2B distributor of medical, pharmaceutical, and consumer health products into Asian markets, though significantly larger and broader in scope.
• Hyphens Pharma International: Singapore-listed specialty pharmaceutical and consumer healthcare company that distributes proprietary and third-party dermatology and aesthetics products across Southeast Asia. Direct competitor in medical aesthetic distribution with overlapping dermatology and skincare portfolios.
• Ebeon Pharma: Asia-based pharmaceutical and aesthetics distributor serving clinics with dermatology and medical aesthetic products. Closely comparable business model of authorized regional distribution of medical-grade skincare and aesthetic brands.

Broad incumbents

• Eurosurgical: Specialist distributor of medical and aesthetic devices including lasers and consumables to clinics. Comparable as a channel partner in medical aesthetic equipment distribution, though primarily UK-rooted rather than Asia-focused.
• Galderma: Global dermatology-focused pharmaceutical company (Nestlé Health Science owned) selling prescription aesthetics, skincare, and injectables. Comparable as both a principal that competes with Neoasia's principals and a benchmark for dermatology product categories Neoasia distributes into clinics.
• Allergan Aesthetics (AbbVie): Global aesthetics leader (Botox, fillers, skincare) and an example of a brand owner moving toward direct Asia operations. Comparable as a competitive threat as a principal that may bypass distributors like Neoasia in key Asian markets.
• Cynosure (Hologic): Global medical aesthetic laser and energy-based device manufacturer (under Hologic). Comparable as a competing device principal whose products overlap Neoasia's laser/IPL portfolio (DEKA, Syneron Candela, Quanta).
• L'Oréal Dermatological Beauty: Division of L'Oréal operating medical-grade skincare brands (SkinCeuticals, La Roche-Posay, CeraVe). Comparable as a competitor in physician-dispensed and clinic-channel skincare categories where Neoasia's principals compete.

Others

• Hydrafacial: Global hydradermabrasion device brand currently distributed by Neoasia in parts of Asia. Comparable both as a principal in the distributed portfolio and as a benchmark of the kind of consumer-facing aesthetic equipment brand Neoasia's channel serves.

Emerging players

• Sinclair Pharma: Aesthetics-focused pharmaceutical company with injectable and bio-stimulator products (e.g., Ellansé, MaiLi) distributed globally. Comparable as a competing injectable principal whose Asia channel strategy overlaps with Neoasia's IBSA/Profhilo lines.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

• Xx.com/neoasiasg
• Facebookfacebook.com/neoasiaofficial
• LinkedInlinkedin.com/company/neoasia-singapore

Revenue estimate

Valuation estimate

Number of profiles

Profiles2 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Neoasia